Differential role of C5a receptor and CD14 in E. coli-induced upregulation of granulocyte and monocyte CD11b (CR3) in human whole blood

被引：0
|
作者：
Brekke, OL
Fure, H
Christiansen, D
Fung, M
Mollnes, TE
机构：
[1] Univ Tromso, Dept Med Biochem, N-9001 Tromso, Norway
[2] Nordland Cent Hosp, Dept Immunol & Transfus Med, Bodo, Norway
[3] Tanox Biosyst Inc, Houston, TX 77025 USA
[4] Aker Univ Hosp, Rikshosp, Inst Immunol, Oslo, Norway
来源：
MOLECULAR IMMUNOLOGY | 2003年 / 40卷 / 2-4期
关键词：
C5a receptor; complement receptor 3 (CR3);
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：180 / 181
页数：2
相关论文
共 47 条
  • [41] Phagocytosis of live and dead Escherichia coli and Staphylococcus aureus in human whole blood is markedly reduced by combined inhibition of C5aR1 and CD14
    Skjeflo, E. W.
    Christiansen, D.
    Landsem, A.
    Stenvik, J.
    Woodruff, T. M.
    Espevik, T.
    Nielsen, E. W.
    Mollnes, T. E.
    MOLECULAR IMMUNOLOGY, 2019, 112 : 131 - 139
  • [42] MUTAGENESIS OF THE ARG-GLY-ASP TRIPLET IN HUMAN-COMPLEMENT COMPONENT-C3 DOES NOT ABOLISH BINDING OF IC3B TO THE LEUKOCYTE INTEGRIN COMPLEMENT RECEPTOR TYPE-III (CR3, CD11B/CD18)
    TANIGUCHISIDLE, A
    ISENMAN, DE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (01) : 635 - 643
  • [43] HYPOXIA FOLLOWED BY WHOLE BLOOD REOXYGENATION INDUCED ENDOTHELIAL CELL ACTIVATION IN A COMPLEMENT C5 AND TOLL-LIKE RECEPTOR CD14 DEPENDENT MANNER
    Sokolova, Marina
    Ekholt, Karin
    Mollnes, Tom Eirik
    Pischke, Soren Erik
    MOLECULAR IMMUNOLOGY, 2019, 114 : 479 - 479
  • [44] Ornithodoros moubata complement inhibitor (OmCI) is an equally effective C5 inhibitor in pig and human, and combined with CD14 inhibition, efficiently attenuate Escherichia coli-induced sepsis in pigs
    Barratt-Due, A.
    Thorgersen, E. B.
    Lindstad, J. K.
    Pharo, A.
    Lambris, J. D.
    Nunn, M. A.
    Mollnes, T. E.
    MOLECULAR IMMUNOLOGY, 2011, 48 (14) : 1699 - 1699
  • [45] Human Endothelial Cell Activation by Escherichia coli and Staphylococcus aureus Is Mediated by TNF and IL-1β Secondarily to Activation of C5 and CD14 in Whole Blood
    Nymo, Stig
    Gustavsen, Alice
    Nilsson, Per H.
    Lau, Corinna
    Espevik, Terje
    Mollnes, Tom Eirik
    JOURNAL OF IMMUNOLOGY, 2016, 196 (05): : 2293 - 2299
  • [46] INTERACTIONS OF HUMAN-COMPLEMENT COMPONENT C3 WITH FACTOR AND AND WITH COMPLEMENT RECEPTORS TYPE-1 (CR-1, CD35) AND TYPE-3 (CR3, CD11B/CD18) INVOLVE AN ACIDIC SEQUENCE AT THE N-TERMINUS OF C3 ALPHA'-CHAIN
    TANIGUCHISIDLE, A
    ISENMAN, DE
    JOURNAL OF IMMUNOLOGY, 1994, 153 (11): : 5285 - 5302
  • [47] Combined C5aR1 and CD14 inhibition significantly reduced cytokine release induced by both viable and heat inactivated bacteria in human whole blood
    Christiansen, Dorte
    Skjeflo, Espen Waage
    Landsem, Anne
    Fure, Hilde
    Ludviksen, Judith K.
    Stenvik, Jurgen
    Woodruff, Trent
    Espevik, Terje
    Mollnes, Tom Eirik
    MOLECULAR IMMUNOLOGY, 2017, 89 : 169 - 170
12345